Hücresel Temeller ve Normal Hücre Döngüsü

Alberts B, Bray D, Hopkin K, Johnson AD, Lewis J, Raff M, et al. Essential cell biology: Garland Science; 2015.

Lodish HF. Molecular cell biology: Macmillan; 2008.

Murray AW, Hunt T. The cell cycle: an introduction: Oxford University Press New York; 1993.

Hoeijmakers JH. DNA damage, aging, and cancer. New England journal of medicine. 2009;361(15):1475-85.

Elmore S. Apoptosis: a review of programmed cell death. Toxicologic pathology. 2007;35(4):495-516.

Laplante M, Sabatini DM. mTOR signaling in growth control and disease. cell. 2012;149(2):274-93.

Lynch M, Marinov GK. The bioenergetic costs of a gene. Proceedings of the National Academy of Sciences. 2015;112(51):15690-5.

Lückmann M, Trauelsen M, Frimurer TM, Schwartz TW. Structural basis for GPCR signaling by small polar versus large lipid metabolites—discovery of non-metabolite ligands. Current Opinion in Cell Biology. 2020;63:38-48.

Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168(4):657-69.

Schmoller KM, Skotheim JM. The biosynthetic basis of cell size control. Trends in cell biology. 2015;25(12):793-802.

Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960-76.

Roskoski Jr R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacological research. 2012;66(2):105-43.

Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169(3):381-405.

Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291-310.

Lempiäinen H, Shore D. Growth control and ribosome biogenesis. Current opinion in cell biology. 2009;21(6):855-63.

Hardie DG. AMPK—sensing energy while talking to other signaling pathways. Cell metabolism. 2014;20(6):939-52.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. cell. 2011;144(5):646-74.

Morgan DO. The cell cycle: principles of control: New science press; 2007.

Pardee AB. G1 events and regulation of cell proliferation. Science. 1989;246(4930):603-8.

Barnum KJ, O’Connell MJ. Cell cycle regulation by checkpoints. Cell cycle control: mechanisms and protocols: Springer; 2014. p. 29-40.

Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes & development. 1999;13(12):1501-12.

22. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Current opinion in cell biology. 2007;19(2):238-23. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nature reviews Molecular cell biology. 2007;8(5):379-93.

McIntosh JR. Mitosis. Cold Spring Harbor perspectives in biology. 2016;8(9):a023218.

Hunter N. Meiotic recombination: the essence of heredity. Cold Spring Harbor perspectives in biology. 2015;7(12):a016618.

Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nature Reviews Cancer. 2020;20(8):471-80.

Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432(7015):316-23.

Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nature reviews cancer. 2009;9(3):153-66.

Lindahl T, Barnes D, editors. Repair of endogenous DNA damage. Cold Spring Harbor symposia on quantitative biology; 2000: Cold Spring Harbor Laboratory Press.

Krokan HE, Bjørås M. Base excision repair. Cold Spring Harbor perspectives in biology. 2013;5(4):a012583.

Jiricny J. Postreplicative mismatch repair. Cold Spring Harbor perspectives in biology. 2013;5(4):a012633.

Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nature reviews Molecular cell biology. 2010;11(3):196-207.

Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Molecular cell. 2010;40(2):179-204.

Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nature reviews genetics. 2016;17(8):487-500.

Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nature reviews Molecular cell biology. 2009;10(11):741-54.

Bartel DP. Metazoan micrornas. Cell. 2018;173(1):20-51.

Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 2009;136(4):731-45.

Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683-92.

Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. cell. 1997;88(3):347-54.

Green DR, Droin N, Pinkoski M. Activation‐induced cell death in T cells. Immunological reviews. 2003;193(1):70-81.

Beltz BS, Pontes M, Helluy SM, Kravitz EA. Patterns of appearance of serotonin and proctolin immunoreactivities in the developing nervous system of the American lobster. Journal of neurobiology. 1990;21(4):521-42.

Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. British journal of cancer. 1972;26(4):239-57.

Reed JC. Mechanisms of apoptosis. The American journal of pathology. 2000;157(5):1415-30.

Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nature reviews Molecular cell biology. 2010;11(9):621-32.

Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews Molecular cell biology. 2008;9(1):47-59.

Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. science. 1998;281(5381):1305-8.

Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405(6782):85-90.

Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Neoplasia. 2000;2(4):291-9.

AKIN H. Hücre Döngüsü, Döngü Kontrol Genleri, DNA Tamir Mekanizmaları ve Apoptozis. Turkiye Klinikleri Medical Genetics-Special Topics. 2017;2(2):69-73.

Vermeulen K, Berneman ZN, Van Bockstaele DR. Cell cycle and apoptosis. Cell proliferation. 2003;36(3):165-75.

Certo M, Moore VDG, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer cell. 2006;9(5):351-65.